Smith & Nephew (SNN) Earning Somewhat Favorable Press Coverage, Study Finds

News coverage about Smith & Nephew (NYSE:SNN) has been trending somewhat positive on Sunday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by analyzing more than 6,000 blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Smith & Nephew earned a news sentiment score of 1.24 on their scale. InfoTrie also assigned media headlines about the medical equipment provider an news buzz score of 6 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the company’s share price in the near term.

A number of equities research analysts recently weighed in on SNN shares. Zacks Investment Research raised Smith & Nephew from a “hold” rating to a “buy” rating and set a $40.00 price target for the company in a report on Wednesday, August 29th. Canaccord Genuity reissued a “buy” rating and issued a $42.00 target price on shares of Smith & Nephew in a research note on Monday, August 6th. HSBC cut Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Tuesday, October 16th. Finally, UBS Group cut Smith & Nephew from a “buy” rating to a “neutral” rating in a research note on Wednesday, August 8th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the stock. Smith & Nephew currently has an average rating of “Hold” and a consensus target price of $41.00.

NYSE SNN opened at $37.26 on Friday. The firm has a market capitalization of $16.30 billion, a PE ratio of 19.61, a PEG ratio of 3.02 and a beta of 0.58. Smith & Nephew has a 52 week low of $32.22 and a 52 week high of $39.85. The company has a quick ratio of 1.05, a current ratio of 2.13 and a debt-to-equity ratio of 0.31.

TRADEMARK VIOLATION WARNING: “Smith & Nephew (SNN) Earning Somewhat Favorable Press Coverage, Study Finds” was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at

Smith & Nephew Company Profile

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Featured Article: How To Calculate Debt-to-Equity Ratio

Insider Buying and Selling by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit